T2Candida MR as a predictor of outcome in patients with suspected invasive candidiasis starting empirical antifungal treatment: a prospective pilot study | Zendy

Patricia Muñóz | Zendy; Antonio Vena | Zendy; Marina Machado | Zendy; Francesca Gioia | Zendy; M. Carmen Martínez-Jiménez | Zendy; Elia Gómez | Zendy; Julia Origüen | Zendy; María Ángeles Orellana | Zendy; Francisco LópezMedrano | Zendy; Mario FernándezRuiz | Zendy; Paloma Merino | Zendy; Fernando GonzálezRomo | Zendy; Isabel Frías | Zendy; María Jesús Pérez-Granda | Zendy; José María Aguado | Zendy; Jesús Fortün | Zendy; Emilio Bouza | Zendy; Carmen Martínez-Jiménez | Zendy; Raquel Navarro | Zendy; Ma Jesús Pérez-Granda | Zendy; Carlos del Fresno | Zendy; Mario Fernández Ruiz | Zendy

Open Access

T2Candida MR as a predictor of outcome in patients with suspected invasive candidiasis starting empirical antifungal treatment: a prospective pilot study

Author(s) -

Patricia Muñóz,

Antonio Vena,

Marina Machado,

Francesca Gioia,

M. Carmen Martínez-Jiménez,

Elia Gómez,

Julia Origüen,

María Ángeles Orellana,

Francisco LópezMedrano,

Mario FernándezRuiz,

Paloma Merino,

Fernando GonzálezRomo,

Isabel Frías,

María Jesús Pérez-Granda,

José María Aguado,

Jesús Fortün,

Emilio Bouza,

Carmen Martínez-Jiménez,

Raquel Navarro,

Ma Jesús Pérez-Granda,

Carlos del Fresno,

Mario Fernández Ruiz

Publication year - 2018

Publication title -

journal of antimicrobial chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.124

H-Index - 194

eISSN - 1460-2091

pISSN - 0305-7453

DOI - 10.1093/jac/dky047

Subject(s) - invasive candidiasis , antifungal , medicine , prospective cohort study , empirical treatment , intensive care medicine , mycosis , fluconazole , surgery , antibiotics , dermatology , microbiology and biotechnology , biology

We assessed the potential role of T2Candida MR (T2MR) and serological biomarkers [β-d-glucan (BDG) or Candida albicans germ tube antibodies (CAGTA)], alone or in combination with standard cultures, for identifying patients with suspected invasive candidiasis (IC), who may benefit from maintaining antifungal therapy.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research